British Journal of Anaesthesia, 2000, Vol. 85, No. 3 344-346
© 2000 The Board of Management and Trustees of the British Journal of Anaesthesia
Editorial |
Editorial II
Ropivacaine in children
Ropivacaine is the s-enantiomer of a new amide local anaesthetic which has been extensively evaluated in adults and older children.1 Recently, it has been used in younger children and several studies have reported its clinical efficacy and safety when administered for caudal epidural analgesia,213 for lumbar epidural block,14 for peripheral nerve blockade,15 16 and as a continuous epidural infusion.1720 Pharmacokinetic parameters have been calculated for several different age groups and the pharmacodynamics in children are becoming clearer as clinical experience grows. A meta-analysis of neonatal outcome after maternal administration of ropivacaine has also been published recently.21
Ropivacaine has several properties which may be useful in paediatric practice, namely the potential to produce differential neural blockade with less motor
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N S Morton Management of postoperative pain in children Arch. Dis. Child. Ed. Pract., February 1, 2007; 92(1): ep14 - ep19. [Full Text] [PDF] |
||||
![]() |
P.-A. Lonnqvist and N. S. Morton Postoperative analgesia in infants and children Br. J. Anaesth., July 1, 2005; 95(1): 59 - 68. [Full Text] [PDF] |
||||

